Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autism Spectrum Disorder | 11 | 2022 | 69 | 2.490 |
Why?
|
| Chromosome Disorders | 8 | 2023 | 19 | 1.920 |
Why?
|
| Child Development Disorders, Pervasive | 14 | 2014 | 25 | 1.460 |
Why?
|
| Autistic Disorder | 11 | 2012 | 48 | 1.070 |
Why?
|
| Memantine | 1 | 2021 | 12 | 0.780 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2021 | 23 | 0.780 |
Why?
|
| Intellectual Disability | 3 | 2020 | 48 | 0.760 |
Why?
|
| Neuropsychological Tests | 6 | 2021 | 1317 | 0.740 |
Why?
|
| Child | 25 | 2021 | 1428 | 0.740 |
Why?
|
| Chromosome Deletion | 9 | 2023 | 28 | 0.730 |
Why?
|
| Cognition | 7 | 2021 | 1429 | 0.690 |
Why?
|
| Memory | 1 | 2021 | 330 | 0.670 |
Why?
|
| Social Skills | 3 | 2021 | 18 | 0.580 |
Why?
|
| Play and Playthings | 1 | 2014 | 8 | 0.490 |
Why?
|
| Psychotherapy, Group | 1 | 2014 | 30 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 22 | 8 | 2023 | 18 | 0.490 |
Why?
|
| Psychotropic Drugs | 2 | 2014 | 24 | 0.430 |
Why?
|
| Stereotypic Movement Disorder | 2 | 2012 | 3 | 0.420 |
Why?
|
| Social Behavior | 6 | 2014 | 103 | 0.420 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2012 | 465 | 0.410 |
Why?
|
| Nerve Tissue Proteins | 4 | 2023 | 176 | 0.360 |
Why?
|
| Male | 29 | 2021 | 16488 | 0.360 |
Why?
|
| Humans | 41 | 2023 | 31059 | 0.350 |
Why?
|
| Female | 26 | 2021 | 17005 | 0.330 |
Why?
|
| Child, Preschool | 12 | 2021 | 689 | 0.290 |
Why?
|
| Genome-Wide Association Study | 4 | 2012 | 320 | 0.280 |
Why?
|
| Double-Blind Method | 7 | 2021 | 499 | 0.280 |
Why?
|
| Adolescent | 14 | 2020 | 2400 | 0.270 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2020 | 86 | 0.260 |
Why?
|
| DNA Copy Number Variations | 4 | 2014 | 10 | 0.260 |
Why?
|
| Gyrus Cinguli | 2 | 2017 | 19 | 0.250 |
Why?
|
| Communication | 2 | 2017 | 120 | 0.250 |
Why?
|
| Pilot Projects | 3 | 2021 | 427 | 0.240 |
Why?
|
| Brain | 5 | 2021 | 1800 | 0.240 |
Why?
|
| Treatment Outcome | 8 | 2021 | 3808 | 0.230 |
Why?
|
| Basal Ganglia | 2 | 2018 | 23 | 0.220 |
Why?
|
| Valproic Acid | 3 | 2009 | 30 | 0.220 |
Why?
|
| Transcriptome | 1 | 2022 | 89 | 0.200 |
Why?
|
| Behavior | 1 | 2021 | 24 | 0.190 |
Why?
|
| Galvanic Skin Response | 3 | 2017 | 10 | 0.190 |
Why?
|
| Genetic Variation | 3 | 2010 | 113 | 0.190 |
Why?
|
| Computers | 1 | 2021 | 27 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2018 | 1321 | 0.190 |
Why?
|
| Oxytocin | 2 | 2014 | 9 | 0.190 |
Why?
|
| Young Adult | 9 | 2020 | 2057 | 0.190 |
Why?
|
| Child Behavior Disorders | 2 | 2010 | 24 | 0.180 |
Why?
|
| Gene Dosage | 2 | 2010 | 25 | 0.170 |
Why?
|
| Fluoxetine | 2 | 2012 | 33 | 0.170 |
Why?
|
| Cerebellum | 1 | 2018 | 53 | 0.160 |
Why?
|
| Adult | 13 | 2018 | 8945 | 0.150 |
Why?
|
| White Matter | 1 | 2020 | 157 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 318 | 0.150 |
Why?
|
| Pain Perception | 1 | 2017 | 6 | 0.150 |
Why?
|
| Anticipation, Psychological | 1 | 2017 | 8 | 0.150 |
Why?
|
| Compulsive Behavior | 2 | 2008 | 6 | 0.140 |
Why?
|
| Stereotyped Behavior | 2 | 2005 | 19 | 0.130 |
Why?
|
| Caregivers | 1 | 2017 | 156 | 0.130 |
Why?
|
| Asperger Syndrome | 3 | 2014 | 5 | 0.130 |
Why?
|
| Anticonvulsants | 2 | 2006 | 112 | 0.130 |
Why?
|
| New York | 1 | 2014 | 10 | 0.120 |
Why?
|
| Empathy | 1 | 2015 | 40 | 0.120 |
Why?
|
| Visual Cortex | 1 | 2014 | 8 | 0.120 |
Why?
|
| Contrast Sensitivity | 1 | 2014 | 6 | 0.120 |
Why?
|
| Visual Pathways | 1 | 2014 | 7 | 0.120 |
Why?
|
| Prospective Studies | 2 | 2017 | 1897 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 14 | 0.120 |
Why?
|
| Autonomic Nervous System | 1 | 2014 | 20 | 0.120 |
Why?
|
| Antimanic Agents | 2 | 2009 | 10 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Genome, Human | 2 | 2010 | 50 | 0.100 |
Why?
|
| Chromosome Duplication | 1 | 2012 | 2 | 0.100 |
Why?
|
| Paternal Age | 1 | 2011 | 1 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2012 | 81 | 0.100 |
Why?
|
| Haplotypes | 1 | 2011 | 64 | 0.100 |
Why?
|
| Nerve Net | 1 | 2011 | 52 | 0.100 |
Why?
|
| Endocrine Disruptors | 1 | 2010 | 1 | 0.090 |
Why?
|
| Emotions | 1 | 2011 | 89 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2012 | 185 | 0.090 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2010 | 24 | 0.090 |
Why?
|
| Irritable Mood | 2 | 2009 | 6 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 197 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2010 | 103 | 0.090 |
Why?
|
| Genotype | 4 | 2012 | 428 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2009 | 26 | 0.080 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2008 | 5 | 0.080 |
Why?
|
| Mutation | 1 | 2010 | 407 | 0.080 |
Why?
|
| Serotonin | 1 | 2008 | 37 | 0.080 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 820 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2012 | 356 | 0.070 |
Why?
|
| Electroencephalography | 2 | 2021 | 136 | 0.070 |
Why?
|
| Piracetam | 1 | 2006 | 15 | 0.070 |
Why?
|
| Oxytocics | 1 | 2006 | 2 | 0.070 |
Why?
|
| Brain Mapping | 3 | 2015 | 193 | 0.070 |
Why?
|
| Parents | 2 | 2021 | 110 | 0.070 |
Why?
|
| Neurons | 1 | 2009 | 377 | 0.070 |
Why?
|
| Organ Size | 2 | 2018 | 108 | 0.060 |
Why?
|
| Psychometrics | 2 | 2020 | 270 | 0.060 |
Why?
|
| Neural Pathways | 2 | 2015 | 83 | 0.060 |
Why?
|
| Photic Stimulation | 2 | 2014 | 44 | 0.060 |
Why?
|
| Sphingolipids | 1 | 2022 | 4 | 0.050 |
Why?
|
| Metabolomics | 1 | 2022 | 23 | 0.050 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 1936 | 0.050 |
Why?
|
| Phenotype | 1 | 2023 | 379 | 0.050 |
Why?
|
| Placebos | 3 | 2006 | 79 | 0.050 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 34 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2022 | 91 | 0.050 |
Why?
|
| Alleles | 2 | 2012 | 236 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2011 | 2041 | 0.050 |
Why?
|
| Risk Factors | 3 | 2012 | 2587 | 0.050 |
Why?
|
| Behavior Rating Scale | 1 | 2020 | 3 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2021 | 244 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2021 | 151 | 0.040 |
Why?
|
| Europe | 2 | 2010 | 80 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 226 | 0.040 |
Why?
|
| Reference Values | 2 | 2012 | 231 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2018 | 30 | 0.040 |
Why?
|
| Logistic Models | 2 | 2011 | 410 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2010 | 661 | 0.040 |
Why?
|
| Schools | 1 | 2018 | 51 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2018 | 144 | 0.040 |
Why?
|
| Consensus | 1 | 2018 | 112 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1506 | 0.030 |
Why?
|
| Middle Aged | 4 | 2012 | 10235 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2015 | 42 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2015 | 30 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2015 | 41 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2014 | 4 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2014 | 7 | 0.030 |
Why?
|
| Multigene Family | 1 | 2014 | 12 | 0.030 |
Why?
|
| Linear Models | 1 | 2015 | 272 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2014 | 13 | 0.030 |
Why?
|
| Pedigree | 1 | 2014 | 75 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2014 | 14 | 0.030 |
Why?
|
| Administration, Intranasal | 1 | 2014 | 26 | 0.030 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2014 | 42 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 100 | 0.030 |
Why?
|
| Facial Expression | 1 | 2013 | 16 | 0.030 |
Why?
|
| Animals | 2 | 2014 | 4713 | 0.030 |
Why?
|
| Visual Perception | 1 | 2013 | 48 | 0.030 |
Why?
|
| Affect | 1 | 2013 | 66 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2014 | 301 | 0.030 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 8 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 2012 | 21 | 0.030 |
Why?
|
| Language Development | 1 | 2012 | 7 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2012 | 73 | 0.030 |
Why?
|
| Social Adjustment | 1 | 2012 | 31 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2012 | 5 | 0.030 |
Why?
|
| Obsessive Behavior | 1 | 2012 | 1 | 0.030 |
Why?
|
| Atrophy | 1 | 2012 | 103 | 0.030 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 4 | 0.030 |
Why?
|
| Maternal Age | 1 | 2011 | 14 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2011 | 8 | 0.030 |
Why?
|
| Siblings | 1 | 2011 | 19 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2011 | 46 | 0.020 |
Why?
|
| Nuclear Family | 1 | 2011 | 16 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 25 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 52 | 0.020 |
Why?
|
| Pain | 1 | 2015 | 426 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2011 | 75 | 0.020 |
Why?
|
| Demography | 1 | 2011 | 81 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 416 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2010 | 43 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2010 | 11 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2010 | 9 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 107 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 586 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 575 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 508 | 0.020 |
Why?
|
| Cell Movement | 1 | 2010 | 105 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2009 | 41 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 872 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2009 | 2 | 0.020 |
Why?
|
| Pregnancy | 1 | 2010 | 404 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 167 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2009 | 80 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2010 | 498 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 1134 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 409 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 1210 | 0.020 |
Why?
|
| Child Behavior | 1 | 2006 | 34 | 0.020 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2006 | 28 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 73 | 0.020 |
Why?
|
| Speech | 1 | 2006 | 28 | 0.020 |
Why?
|
| Comprehension | 1 | 2006 | 29 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2006 | 30 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 924 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2006 | 326 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2005 | 20 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2005 | 75 | 0.020 |
Why?
|
| Intelligence | 1 | 2005 | 26 | 0.020 |
Why?
|
| Mental Status Schedule | 1 | 2005 | 121 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2005 | 89 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2005 | 132 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 111 | 0.020 |
Why?
|